Baker McKenzie advised Galapagos on the deal. Galapagos plans to separate into two distinct publicly traded companies. As part of this separation, one entity will be...
Galapagos’ Separation into Two Publicly Traded Entities
NovAliX’s Signature of a Strategic Collaboration Agreement with Galapagos
Bird & Bird is advising NovAliX in this transaction. Galapagos was advised by Baker & Mackenzie and Capstan. NovAliX, a leading integrated drug discovery company, and...